These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1094054)

  • 41. Experimental cryptococcosis in guinea pigs.
    Riera CM; Masih DT; Nobile R
    Mycopathologia; 1983 Jun; 82(3):179-84. PubMed ID: 6350885
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cryptococcus neoformans-specific oligoclonal immunoglobulins in cerebrospinal fluid in cryptococcal meningitis.
    Porter KG; Sinnamon DG; Gillies RR
    Lancet; 1977 Jun; 1(8024):1262. PubMed ID: 68362
    [No Abstract]   [Full Text] [Related]  

  • 43. [Fever of unknown origin and cryptococcal antigen].
    Torroba Alvarez L; Fortún Abete J; Buzón Rueda L; Moreno Caparrós A
    Med Clin (Barc); 1988 Oct; 91(13):514. PubMed ID: 3067009
    [No Abstract]   [Full Text] [Related]  

  • 44. The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection.
    Diamond RD; May JE; Kane MA; Frank MM; Bennett JE
    J Immunol; 1974 Jun; 112(6):2260-70. PubMed ID: 4596700
    [No Abstract]   [Full Text] [Related]  

  • 45. Role of macrophages in immunity and pathogenesis of experimental cryptococcosis induced by the airborne route--Part II: Phagocytosis and intracellular fate of Cryptococcus neoformans.
    Karaoui RM; Hall NK; Larsh HW
    Mykosen; 1977 Nov; 20(11):409-12. PubMed ID: 339078
    [No Abstract]   [Full Text] [Related]  

  • 46. Cellular immunity in a cutaneous model of cryptococcosis.
    Domer JE; Lyon FL; Murphy JW
    Infect Immun; 1983 Jun; 40(3):1052-9. PubMed ID: 6343238
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Host immunity to Cryptococcus neoformans.
    Rohatgi S; Pirofski LA
    Future Microbiol; 2015; 10(4):565-81. PubMed ID: 25865194
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cryptococcal culture filtrate antigen for detection of delayed-type hypersensitivity in cryptococcosis.
    Murphy JW; Pahlavan N
    Infect Immun; 1979 Jul; 25(1):284-92. PubMed ID: 383616
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cryptococcal immunity and immunostimulation.
    Murphy JW
    Adv Exp Med Biol; 1992; 319():225-30. PubMed ID: 1414597
    [No Abstract]   [Full Text] [Related]  

  • 50. Heat killed cells of Cryptococcus neoformans var. grubii induces protective immunity in rats: immunological and histopathological parameters.
    Baronetti JL; Chiapello LS; Aoki MP; Gea S; Masih DT
    Med Mycol; 2006 Sep; 44(6):493-504. PubMed ID: 16966166
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lymphocyte transformation assay for C neoformans antigen is not reliable for detecting cellular impairment in patients with neurocryptococcosis.
    Rocha KC; Pinhal C; Cavalcanti S; Vidal MS; Toscano M; Moraes-Vasconcelos D; Duarte AJ; Fonseca FL; de Abreu LC; Valenti VE; Grumach AS
    BMC Infect Dis; 2012 Oct; 12():278. PubMed ID: 23110700
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Generation of antifungal effector CD8+ T cells in the absence of CD4+ T cells during Cryptococcus neoformans infection.
    Lindell DM; Moore TA; McDonald RA; Toews GB; Huffnagle GB
    J Immunol; 2005 Jun; 174(12):7920-8. PubMed ID: 15944298
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protection against cryptococcosis by using a murine gamma interferon-producing Cryptococcus neoformans strain.
    Wormley FL; Perfect JR; Steele C; Cox GM
    Infect Immun; 2007 Mar; 75(3):1453-62. PubMed ID: 17210668
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methodology for Anti-Cryptococcal Vaccine Development.
    Chaturvedi AK; Wormley FL
    Methods Mol Biol; 2017; 1625():129-140. PubMed ID: 28584988
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of macrophage inflammatory protein-1 alpha/CCL3 in regulation of T cell-mediated immunity to Cryptococcus neoformans infection.
    Olszewski MA; Huffnagle GB; McDonald RA; Lindell DM; Moore BB; Cook DN; Toews GB
    J Immunol; 2000 Dec; 165(11):6429-36. PubMed ID: 11086082
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of enzyme immunoassay and latex agglutination methods for detection of Cryptococcus neoformans antigen.
    Scott EN; Muchmore HG; Felton FG
    Am J Clin Pathol; 1980 Jun; 73(6):790-4. PubMed ID: 6994479
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD8 cells play a critical role in delayed type hypersensitivity to intact Cryptococcus neoformans.
    Mody CH; Paine R; Jackson C; Chen GH; Toews GB
    J Immunol; 1994 Apr; 152(8):3970-9. PubMed ID: 8144964
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of rats with heat killed cells (HKC) of Cryptococcus neoformans var. grubii induces cellular activation in spleen and lymphatic nodes.
    Baronetti JL; Chiapello LS; Garro AP; Masih DT
    Comp Immunol Microbiol Infect Dis; 2011 Jul; 34(4):327-34. PubMed ID: 21592577
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dendritic cells in the induction of protective and nonprotective anticryptococcal cell-mediated immune responses.
    Bauman SK; Nichols KL; Murphy JW
    J Immunol; 2000 Jul; 165(1):158-67. PubMed ID: 10861048
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of host immune responses to pulmonary cryptococcosis using a temperature-sensitive C. neoformans calcineurin A mutant strain.
    Wormley FL; Cox GM; Perfect JR
    Microb Pathog; 2005; 38(2-3):113-23. PubMed ID: 15748813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.